Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

Обзор

Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes. This trial aims to evaluate whether management through the "Yueya" mini-program and WeChat can provide personalized guidance such as health education, diet, exercise, medication supervision, and condition monitoring to enhance treatment compliance, quality of life, strengthen quality control in the hemodialysis unit, and improve patient prognosis. Patients will be divided into a group receiving support via the "Yueya" mini-program and WeChat, and a control group receiving routine care. Clinical and laboratory indicators, cardiovascular events, death, hospitalization, quality of life, and compliance will be recorded and compared between groups to assess the impact of APP-assisted patient management on the quality of MHD blood purification therapy and the prognosis of MHD patients.

Подробное описание

Affected by their own diseases and various complications, many maintenance hemodialysis (MHD) patients have a negative and pessimistic attitude toward life. Their quality of life and prognosis have always been a concern for clinicians. Therefore, how to adjust and manage the lives of these patients, enable them to actively cooperate with various treatment methods, maximize the quality of blood purification therapy, and improve their quality of life and prognosis has become an extremely important research topic.

Вмешательства

• Поведенческое APP-based management
  Based on patients' specific conditions such as age, gender, primary disease, and complications, the APP-based management will provide individualized and round-the-clock guidance for dialysis patients in their daily lives through the "Yueya" mini-program and WeChat. This guidance covers various aspects, including health knowledge education, diet and exercise guidance, medication supervision, condition monitoring, and real-time feedback.

Первичные конечные точки

• mortality rate [Срок оценки: About 1 year]
• Hospitalization rate [Срок оценки: About 1 year]
• Kidney Disease Quality of Life [Срок оценки: About 1 year]
• Incidence of cardiovascular events [Срок оценки: About 1 year]

Критерии участия

Критерии включения

• Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week.
• Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study.
• Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study.

Критерии исключения

• Patients with communication barriers or other conditions that prevent them from cooperating with the study.
• Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months.
• Patients who are not willing to actively cooperate with the study.
• Patients with severe liver cirrhosis, active tuberculosis and AIDS.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Организация здравоохранения

Центры проведения

Китай · 1 центр

• The First Affiliated Hospital of Chongqing Medical University — Чунцин

Идентификаторы

NCT: NCT07291154 · 1st ChongqingMedicalUniversity

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗